- Home
- / PDS Biotechnology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PDS Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 14.7M | 17.7M | 14.3M | 11.0M | 7.0M | 10.2M | 12.2M | 15.3M | 13.8M | 12.5M |
| Operating expense total | 39.5M | 52.0M | 30.4M | 17.1M | 14.9M | 41.7M | 43.0M | 36.3M | 31.5M | |
| Depreciation and amortization | 15.6K | |||||||||
| EBIT | (39.5M) | (52.0M) | (43.1M) | (21.0M) | (14.9M) | (21.4M) | (41.7M) | (43.0M) | (36.3M) | (31.5M) |
| Investment income | 212.3K | 700.9K | 871.9K | |||||||
| Interest income | 353.5K | 55.0K | 4.3K | 935.2K | 2.9M | 2.5M | 1.2M | |||
| Interest expense | 381.3K | 4.2M | 4.7M | 4.1M | ||||||
| Pre tax profit | (40.7M) | (53.4M) | (43.6M) | (7.4M) | (14.8M) | (21.4M) | (42.1M) | (44.3M) | (38.5M) | (35.7M) |
| Income tax expense | (1.8M) | (2.6M) | (2.8M) | 381.5K | (4.5M) | (1.2M) | (1.4M) | (900.0K) | (1.2M) | |
| Net Income | (38.8M) | (50.9M) | (40.9M) | (7.0M) | (14.8M) | (16.9M) | (40.9M) | (42.9M) | (37.6M) | (34.5M) |
| EPS | (1.4) | (1.4) | (1.0) | (0.7) |